This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatocellular Carcinoma
and you are
between 18 and 75
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This study aims at testing the utility of PET Scan as a screening tool for liver transplantation in patients with Hepatocellular Carcinoma. Patients being worked up for liver transplant for hepatocellular carcinoma will undergo a PET Scan and will be followed until 2 years after transplantation. At that time survival data will be analysed according to PET Scan results to determine if it can be used to predict outcome.

Provided treatments

  • Other: PET Scan

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01320852. The sponsor of the trial is McGill University Health Centre/Research Institute of the McGill University Health Centre and it is looking for 100 volunteers for the current phase.
Official trial title:
PET Scan as a Screening Tool for Liver Transplant in Patients With HCC